Prevention of cardiovascular outcomes in type 2 diabetes mellitus: Trials on the horizon

被引：1
|
作者：
Buse, JB
Rosenstock, J
机构：
[1] Univ N Carolina, Sch Med, Diabet Care Ctr, Div Endocrinol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Diabet Care Ctr, Div Gen Med, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Diabet Care Ctr, Div Clin Epidemiol, Chapel Hill, NC 27599 USA
[4] Dallas Diabet & Endocrine Ctr, Dallas, TX 75230 USA
[5] Univ Texas, SW Med Sch, Dallas, TX 75230 USA
来源：
CARDIOLOGY CLINICS | 2005年 / 23卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.ccl.2004.11.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article focuses on the continuing clinical trials in patients who have diabetes mellitus and pre-diabetes mellitus in which cardiovascular disease outcomes-specifically, myocardial infarction, stroke, and cardiovascular death-are examined as primary outcomes.
引用
收藏
页码：211 / +
页数：11
相关论文
共 50 条
  • [21] Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials
    Allemann, S
    Diem, P
    Egger, M
    Christ, ER
    Stettler, C
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (03) : 617 - 623
  • [22] Know Diabetes by Heart A Partnership to Improve Cardiovascular Outcomes in Type 2 Diabetes Mellitus
    Sanchez, Eduardo J.
    Cefalu, William T.
    [J]. CIRCULATION, 2019, 140 (07) : 526 - 528
  • [23] Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Steiner, George
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 28L - 33L
  • [24] HEART FAILURE OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: FINDINGS FROM THE CARDIOVASCULAR OUTCOME TRIALS OF ANTIDIABETES AGENTS
    Anker, Stefan D.
    [J]. DIABETES MELLITUS, 2019, 22 (05): : 467 - 472
  • [25] Diabetes mellitus and cardiovascular Prevention
    Kellerer, Monika
    Qui, Hui Jing
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (16) : 1033 - 1039
  • [26] Outcomes in women with history of gestational diabetes mellitus Screening and prevention of type 2 diabetes mellitus Literature review
    Verier-Mine, O.
    [J]. JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (08): : S299 - S321
  • [27] No Benefit of Saxagliptin on Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Potential Explanations
    Jialal, Ishwarlal
    Dhindsa, Sandeep
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2014, 12 (03) : 157 - 158
  • [28] Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
    Bangalore, Sripal
    Fayyad, Rana
    DeMicco, David A.
    Colhoun, Helen M.
    Waters, David D.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (11): : e004724
  • [29] Type 2 diabetes mellitus and cardiovascular disease: focus on the effect of antihyperglycemic treatments on cardiovascular outcomes
    Choxi, Ravi
    Roy, Sumon
    Stamatouli, Angeliki
    Mayer, Stephanie B.
    Jovin, Ion S.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (04) : 187 - 199
  • [30] Management of type 2 diabetes mellitus and cardiovascular risk -: Lessons from intervention trials
    Yki-Järvinen, H
    [J]. DRUGS, 2000, 60 (05) : 975 - 983
12345